Technology
New On Robinhood
Health

TCR2 Therapeutics

$14.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.77 (-5.01%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell TCRR and other stocks, options, ETFs, and crypto commission-free!

About

TCR2 Therapeutics Inc. Common Stock, also called TCR2 Therapeutics, is an immunotherapy company, which develops biological drugs and engineering T-cells for cancer therapy. Read More The company offers cancer therapy, T-cell biology, Immunology and Molecular biology. It also engages in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded in May 2015 and is headquartered in Cambridge, MA.

Employees
48
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
365.45M
Price-Earnings Ratio
Dividend Yield
Average Volume
47.25K
High Today
$15.47
Low Today
$13.93
Open Price
$15.47
Volume
33.66K
52 Week High
$25.47
52 Week Low
$13.04

Collections

Technology
New On Robinhood
Health
Pharmaceutical
Therapy
Cancer Prevention
Engineering
2019 IPO

Earnings

-$5.82
-$5.17
-$4.53
-$3.88
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 13, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.